Medical News

RSS

BioAlliance Pharma launches Oravig drug in the U.S. market

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, today announces the launch in the United States of Oravig® (known as Loramyc® in Europe) for the treatment of oropharyngeal candidiasis (OPC) in adults by its commercial partner, Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc..

25 Aug 2010

Researchers develop high-resolution technology to visualize individual virus particles

In the war against infectious disease, identifying the culprit is half the battle. Now, research professor Shaopeng Wang and his colleagues from the Biodesign Institute at Arizona State University, describe a new method for visualizing individual virus particles. Their research opens the door to a more detailed understanding of these minute pathogens, and may further the study of a broad range of micro- and nanoscale phenomena.

25 Aug 2010

Alcohol consumption affects oestrogen levels, increases breast cancer risk: Study

A US study, published in the Journal of the National Cancer Institute, has confirmed suggestions that certain types of breast cancer are more common among women who regularly drink alcohol.

25 Aug 2010

BioPharm Systems enters Inc. magazine's list of fastest-growing private companies in U.S

BioPharm Systems, a leading provider of clinical trial, data, and safety solutions, today announced that it has been named to Inc. magazine's list of the fastest-growing private companies in the United States for 2010. The Inc. 500|5000 ranks companies by overall revenue growth over a three-year period. BioPharm Systems was recognized for its 60 percent three-year growth rate.

25 Aug 2010

Prenatal exposure to atrazine leads to prostate inflammation in male rats

A new study shows that male rats prenatally exposed to low doses of atrazine, a widely used herbicide, are more likely to develop prostate inflammation and to go through puberty later than non-exposed animals. The research adds to a growing body of literature on atrazine, an herbicide predominantly used to control weeds and grasses in crops such as corn and sugar cane. Atrazine and its byproducts are known to be relatively persistent in the environment, potentially finding their way into water supplies.

25 Aug 2010

Dyadic International completes private placement of secured promissory notes

Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced that it has completed a private placement of $3,000,000 in convertible subordinated secured promissory notes (the "Notes") with two investors.

25 Aug 2010

Study examines movement of pediatric drug testing outside the U.S.

"A law intended to speed up development of new drugs for U.S. kids has ended up financing clinical trials in poor countries, where the medicines might never become available," suggest the authors of a study published online Monday in the journal Pediatrics, Reuters reports (Joelving, 8/23).

25 Aug 2010

ACR Image Metrix praises iCAD on FDA clearance of VeraLook Colon CAD software

ACR Image Metrix™, an imaging contract research organization (CRO) with expertise in imaging research design, techniques and data extraction, congratulates their partner, iCAD, Inc., on obtaining U.S. Food and Drug Administration clearance on its VeraLook™, Colon CAD (Computer-Aided Detection) software.

25 Aug 2010

Echo Therapeutics completes clinical study of Prelude SkinPrep System

Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude SkinPrep System for transdermal drug delivery, today announced the completion of a clinical study of Prelude.

25 Aug 2010

NICE draft guidance rejects cancer drug bevacizumab

The National Institute for Health and Clinical Excellence (NICE) has released draft guidance for cancer drug bevacizumab (Avastin).

25 Aug 2010

BioScale installs ViBE analytical tool at Massachusetts-based pharmaceutical company

BioScale Inc., an innovative life science company that develops, manufactures and promotes novel analytical tools enabling advancements in protein research, today announced the first shipment and installation of the ViBE™ Protein Analysis Workstation at a major Massachusetts-based pharmaceutical company.

25 Aug 2010

American Medical Group Association to participate in COPD care management

The American Medical Group Association (AMGA) and the American Medical Group Foundation (AMGF) are pleased to announce an opportunity for AMGA members to participate in a learning collaborative on care management for patients with COPD. The Best Practices Learning Collaborative is for organizations that are striving to improve the care of patients with COPD.

25 Aug 2010

Access Pharmaceuticals to highlight Cobalamin nanotechnology at ACS National Meeting

ACCESS PHARMACEUTICALS, INC.,a biopharmaceutical company specializing in products for cancer and supportive care, announced that its Director of Chemistry and Quality, Dr. Ric Zarzycki will give an invited presentation today on the Company's Cobalamin nanoparticle technology at a thought-leadership symposium being held at the American Chemical Society's ("ACS") 240th National Meeting & Exposition, at Boston Convention and Exhibition Center in Boston, Massachusetts, August 22-26, 2010.

25 Aug 2010

Getting the 4-1-1 on waiting times at the emergency room

The Associated Press: Hospitals are increasingly using messaging systems, such as online notices, text messages or flashing billboards, to let people know how long the wait is at local emergency rooms. "It's a marketing move aimed at less urgent patients, not the true emergencies that automatically go to the front of the line anyway.

25 Aug 2010

Wellington Foods moves to new cGMP compliant manufacturing facility

Wellington Foods, Inc., a leading nutritional supplement manufacturer, has announced the expansion of its production operation to its new headquarters in Corona, California. Moving to the larger state-of-the-art manufacturing facility, Wellington Foods has made a significant commitment to the long-term growth of the company and to the natural products industry.

25 Aug 2010

DSM Biomedical signs new licensing agreements with global medical device manufacturers

DSM Biomedical, a global leader in biomedical materials science, and its Berkeley based operation, DSM PTG, today announced the company has entered into six multi-year licensing agreements with global medical device manufacturers in the Orthopedic, Cardiovascular, Vascular and Urology fields in this year alone.

25 Aug 2010

Cyberonics enters agreement with NeuroVista for epilepsy technology development program

Cyberonics, Inc. today announced that it has entered into additional agreements with NeuroVista Corporation in the field of EEG-based seizure detection to build on its position as the leader in medical devices for epilepsy.

25 Aug 2010

NTI’s EHR technology earns additional certification in CCHIT's Preliminary ARRA IFR Stage 1 program

Networking Technology, Inc., the leader in electronic health solutions, today announced that their electronic health record modular technology, RxNT eHr V 7.0 earned additional certification in CCHIT's Preliminary ARRA IFR Stage 1 program.

25 Aug 2010

UT Southwestern University Hospital - St. Paul earns distinction as Primary Stroke Center

The Joint Commission has certified UT Southwestern University Hospital - St. Paul as a Primary Stroke Center, a distinction for hospitals fostering specialized stroke care for patients.

25 Aug 2010

AdvanSource Biomaterials enters multi-year agreement to supply hydrophilic polymer resins

AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced that the Company has entered into a multi-year supply agreement with a leading multi-national medical device company. This supply agreement is the result of the Company's successful performance on a development agreement, which was entered into with this customer in June 2009.

25 Aug 2010

Medical News

BioAlliance Pharma launches Oravig drug in the U.S. market

Researchers develop high-resolution technology to visualize individual virus particles

Alcohol consumption affects oestrogen levels, increases breast cancer risk: Study

BioPharm Systems enters Inc. magazine's list of fastest-growing private companies in U.S

Prenatal exposure to atrazine leads to prostate inflammation in male rats

Dyadic International completes private placement of secured promissory notes

Study examines movement of pediatric drug testing outside the U.S.

ACR Image Metrix praises iCAD on FDA clearance of VeraLook Colon CAD software

Echo Therapeutics completes clinical study of Prelude SkinPrep System

NICE draft guidance rejects cancer drug bevacizumab

BioScale installs ViBE analytical tool at Massachusetts-based pharmaceutical company

American Medical Group Association to participate in COPD care management

Access Pharmaceuticals to highlight Cobalamin nanotechnology at ACS National Meeting

Getting the 4-1-1 on waiting times at the emergency room

Wellington Foods moves to new cGMP compliant manufacturing facility

DSM Biomedical signs new licensing agreements with global medical device manufacturers

Cyberonics enters agreement with NeuroVista for epilepsy technology development program

NTI’s EHR technology earns additional certification in CCHIT's Preliminary ARRA IFR Stage 1 program

UT Southwestern University Hospital - St. Paul earns distinction as Primary Stroke Center

AdvanSource Biomaterials enters multi-year agreement to supply hydrophilic polymer resins

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News